Neil Herskowitz - 08 Jul 2024 Form 4 Insider Report for Journey Medical Corp (DERM)

Reporting relationship: Director
Issuer ticker: DERM
Reported as of: 08 Jul 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 10 Jul 2024, 16:45:23 UTC
Prior SEC filing: 16 May 2024
Next SEC filing: 25 Sep 2024
Source filing: View source filing
Reporting owner signature: /s/ Ramsey Alloush, attorney-in-fact

Key filing fact

Neil Herskowitz filed Form 4 for Journey Medical Corp (DERM) on 10 Jul 2024.

Key facts

This page summarizes Neil Herskowitz's Form 4 filing for Journey Medical Corp (DERM).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 10 Jul 2024, 16:45.

Change

Previous filing in this sequence was filed on 16 May 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DERM transaction

Common Stock, $0.0001 par value

Award

Transaction value: $0
Shares: +9,728
Change %: +14%
Price: $0.000000
Shares after: 81,445
Date: 08 Jul 2024
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

On July 8, 2024, the reporting person was granted 9,728 restricted stock units pursuant to the Issuer's 2015 Stock Plan, which will vest in full on July 8, 2025.

Footnote F2

Includes restricted stock units, which vest over various time periods.